Logo Logo
Eine Ebene nach oben
Exportieren als [feed] RSS 1.0 [feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 6

Zeitschriftenartikel

Vrhovac, R.; Labopin, M.; Ciceri, F.; Finke, J.; Holler, E.; Tischer, J.; Lioure, B.; Gribben, J.; Kanz, L.; Blaise, D.; Dreger, P.; Held, G.; Arnold, R.; Nagler, A.; Mohty, M. (2016): Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes. In: Bone Marrow Transplantation, Vol. 51, Nr. 2: S. 186-193

Heinzelmann, F.; Bethge, W.; Beelen, D. W.; Engelhard, M.; Kröger, N.; Dreger, P.; Niederwieser, D.; Finke, J.; Bunjes, D.; Tischer, J.; Kobbe, G.; Holler, E.; Bornhäuser, M.; Stelljes, M.; Baurmann, H.; Müller, A.; Haubitz, I.; Schrezenmeier, H.; Müller, C.; Ottinger, H. (2016): Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas. In: Bone Marrow Transplantation, Vol. 51, Nr. 5: S. 654-662

Marchand, T.; Lamy, T.; Finel, H.; Arcese, W.; Choquet, S.; Finke, J.; Huynh, A.; Irrera, G.; Karakasis, D.; Konopacki, J.; Lambert, J.; Michieli, M.; Schouten, H. C.; Schroyens, W.; Sucak, G.; Tischer, J.; Vandenberghe, E.; Dreger, P. (2016): Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation. In: Leukemia, Vol. 30, Nr. 5: S. 1201-1204

Dietrich, S.; Finel, H.; Martinez, C.; Tischer, J.; Blaise, D.; Chevallier, P.; Castagna, L.; Milpied, N.; Bacigalupo, A.; Corradini, P.; Mohty, M.; Sanz, M.; Hausmann, A.; Montoto, S.; Robinson, S.; Boumendil, A.; Sureda, A.; Dreger, P. (2016): Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: a registry study by the European society for blood and marrow transplantation. In: Leukemia, Vol. 30, Nr. 10: S. 2086-2089

Estenfelder, S.; Tausch, E.; Huber, H.; Bloehdorn, J.; Cymbalista, F.; Leblond, V.; Delmer, A.; Ibach, S.; Choquet, S.; Dartigeas, C.; Cazin, B.; Tournilhac, O.; Pegourie, B.; Seiler, T.; Sökler, M.; Zirlik, K.; Alt, J.; Schetelig, J.; Hallek, M.; Dreger, P.; Döhner, H.; Stilgenbauer, S. (2016): Mutation analysis by targeted next generation sequencing in ultra high risk CLL patients treated within the CLL20 study. In: Haematologica, Vol. 101: S. 228-229

Pott, Christiane; Hoster, Eva; Delfau-Larue, M. H.; Beldjord, K.; Böttcher, S.; Asnafi, V.; Plonquet, A.; Siebert, R.; Callet-Bauchu, E.; Andersen, N.; van Dongen, J. J.; Klapper, Wolfram; Berger, F.; Ribrag, Vincent; van Hoof, A. L.; Trneny, Marek; Walewski, J.; Dreger, P.; Unterhalt, Michael; Hiddemann, Wolfgang; Kneba, M.; Kluin-Nelemans, H. C.; Hermine, Olivier; Macintyre, E.; Dreyling, Martin (2010): Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study. In: Blood, Vol. 115, Nr. 16: S. 3215-3223

Diese Liste wurde am Sat Mar 23 16:14:49 2019 CET erstellt.